ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial

BACKGROUND: Although aspirin is recommended for the prevention of colorectal cancer, the specific individuals for whom the benefits outweigh the risks are not clearly defined. Moreover, the precise mechanisms by which aspirin reduces the risk of cancer are unclear. We recently launched the ASPirin I...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Trials
Glavni autori: Drew, David A., Chin, Samantha M., Gilpin, Katherine K., Parziale, Melanie, Pond, Emily, Schuck, Madeline M., Stewart, Kathleen, Flagg, Meaghan, Rawlings, Crystal A., Backman, Vadim, Carolan, Peter J., Chung, Daniel C., Colizzo, Francis P., Freedman, Matthew, Gala, Manish, Garber, John J., Huttenhower, Curtis, Kedrin, Dmitriy, Khalili, Hamed, Kwon, Douglas S., Markowitz, Sanford D., Milne, Ginger L., Nishioka, Norman S., Richter, James M., Roy, Hemant K., Staller, Kyle, Wang, Molin, Chan, Andrew T.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Study Protocol
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5286828/
https://ncbi.nlm.nih.gov/pubmed/28143522
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-016-1744-z
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items